Cite
HARVARD Citation
Yu, X. et al. (n.d.). 223PEfficacy and safety of weekly nab-paclitaxel (nab-P) plus gemcitabine (Gem) in Chinese patients (Pts) with metastatic adenocarcinoma of the pancreas (MPC): A phase II study. Annals of oncology. pp. ix66-ix67. [Online].